Skip to content
Drug recall · FDA · Published November 11, 2020

InvaTech Pharma Solutions, LLC recalls Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc.

InvaTech Pharma Solutions recalls 5mg Levocetirizine tablets that failed stability testing. Affected lots may degrade, causing potential safety issues. Contact for details.

🇺🇸 FDA recall #D-0115-2021DrugInvaTech Pharma Solutions ›
Take action

Contact the company & request your remedy

Recalling firmInvaTech Pharma Solutions, LLC40c Cotters Ln Ste A, N/A · East Brunswick, NJ 08816-2037
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

InvaTech Pharma Solutions is recalling 5 mg Levocetirizine Dihydrochloride Tablets that failed stability testing. This means the tablets could degrade over time, potentially causing safety risks for users. Read more at govinfonow.com/recall/36686-invatech-levocetirizine-tablets-recall-failed-stability-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/36686-invatech-levocetirizine-tablets-recall-failed-stability-testing · Updated October 4, 2026 · FDA enforcement record: FDA #D-0115-2021

Cite this page

“InvaTech Levocetirizine Tablets Recall: Failed Stability Testing.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36686-invatech-levocetirizine-tablets-recall-failed-stability-testing. Based on FDA recall #D-0115-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0115-2021%22&limit=1).

Why it’s dangerous

The tablets failed stability testing, meaning they may degrade over time. This degradation could lead to potential safety issues, though the exact risk is not specified in the recall.

Who’s affected

People with a prescription for 5 mg Levocetirizine tablets from InvaTech Pharma Solutions. Those who have the specific lot numbers listed in the recall are most at risk.

How to tell if you have this one

Check for the product name 'Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle' with the lot numbers 051944A (exp. April 2021), 1119124 (exp. Oct 2021), or 062088 (exp. June 2022).

  • Brand
    InvaTech Pharma Solutions
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot numbers 051944A, 1119124, or 062088 on the packaging to confirm if your tablets are affected.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The tablets failed stability testing, which means they may degrade over time and pose potential safety risks.

What should I do if I have these tablets?

Check the lot number on your packaging. If it matches 051944A, 1119124, or 062088, contact InvaTech Pharma Solutions for further instructions.

Are there any safety risks from using these tablets?

The recall states the tablets may degrade, but the exact risk is not specified. Consult your healthcare provider for advice.

Take action

Contact InvaTech Pharma Solutions

We’ve drafted a message you can send InvaTech Pharma Solutions to request your refund or repair — edit it as you like.

Subject: Recall D-0115-2021 — InvaTech Pharma Solutions InvaTech Pharma Solutions

Hello,

I own a InvaTech Pharma Solutions that is covered by recall D-0115-2021 from InvaTech Pharma Solutions.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0115-2021 (November 11, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0115-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA